Literature DB >> 3713547

An electron microscopic study of the effect of clindamycin on adherence of Staphylococcus aureus to bone surfaces.

K J Mayberry-Carson, W R Mayberry, B K Tober-Meyer, J W Costerton, D W Lambe.   

Abstract

Discs of rabbit tibia, 5 mm thick, were utilized to study the adherence of Staphylococcus aureus to the bone surface in the presence and absence of clindamycin. Bacteria were grown in broth media containing the bone slices and varying concentrations of clindamycin. In the absence of the antibiotic, S. aureus adhered extensively to bone surfaces and formed large microcolonies which were surrounded by an amorphous matrix. In the presence of 0.025 micrograms/ml of clindamycin (0.1 MIC), S. aureus adhered less to bone surfaces, forming smaller and fewer microcolonies. In the presence of 0.0625 micrograms/ml of clindamycin (0.25 MIC), S. aureus adhered to the bone surfaces only sparsely, forming small microcolonies with very little matrix holding them together, and leaving very large areas of the bone surface uncolonized. In the presence of 0.125 micrograms/ml of clindamycin (0.5 MIC), bone surfaces were basically clean, with only one or two cells (no microcolonies) found in crevices and indentations of the bone surface. In the presence of 0.25 micrograms/ml (1 MIC) no bacteria adhered to the bone surfaces.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713547

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  6 in total

1.  Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus.

Authors:  S Herbert; P Barry; R P Novick
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.

Authors:  J T Mader; K Adams; L Morrison
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

4.  Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates.

Authors:  K Ohlsen; W Ziebuhr; K P Koller; W Hell; T A Wichelhaus; J Hacker
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

5.  Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.

Authors:  Valérie Zeller; Arnaud Dzeing-Ella; Marie-Dominique Kitzis; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

6.  Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.

Authors:  Borg Leijtens; Joris B W Elbers; Patrick D Sturm; Bart Jan Kullberg; Berend W Schreurs
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.